Ironwood Pharma (IRWD) Posts Q1 Loss of 38c/Share

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.38), $0.06 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $8.52 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Onsemi bets on physical AI with $7 billion Synaptics acquisition
• American Outdoor Brands (AOUT) Tops Q4 EPS by 14c